NMPA Approval

Moxifloxacin Hydrochloride Eye Drops

Approval Number

国药准字H20237039

Company上海昊海生物科技股份有限公司

Registration Date

April 13, 2023

Previous Approval Numbers

国药准字H20213157

Drug Information

Generic Name

盐酸莫西沙星滴眼液

Dosage Form

眼用制剂

Strength

0.5%(0.4ml:2mg,按C₂₁H₂₄FN₃O₄计）

Drug Type

化学药品

Registration Date

April 13, 2023

Company Information

Applicant Company

Company Name上海昊海生物科技股份有限公司

Company Address

上海市松江工业区洞泾路5号

Manufacturing Company

Company Name北京汇恩兰德制药有限公司

Company Address

北京市通州区靓丽五街3号院7号楼

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸莫西沙星滴眼液 - NMPA 批准文号 | MedPath